The Form 4 filing, a public report of an insider's stock activity, was filed on November 18, 2026. It covers sales from November 16 through November 17, 2026. Daniel Allen Gold is listed as a director of Roivant Sciences Ltd. (ROIV).
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-16 |
| Date of Latest Transaction | 2026-11-17 |
| Buy/Sell | sell |
| Transaction Count | 7 |
| Shares Transacted | 1,381,762 |
| Price | $38.75 |
| Total Transaction Value | $53,536,738.01 |
| Insider | |
| Ticker Symbol | ROIV |
| Company | Roivant Sciences Ltd. |
| Insider Name | Gold Daniel Allen |
| Insider Title | Director |
| Sector - Industry | Healthcare - Biotechnology |
| Holdings | |
| Total Shares Owned After Transaction | 0 |
| Position Size Change | 100.00% |
| Filing | |
| Filing Date | 2026-11-18 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales, reported with transaction code S, which identifies a sale. The seven transactions appear in a single filing by one insider.
What was the average price of the transaction?
The average sale price was $38.75 per share, rounded to the nearest cent. This average covers the seven sales. Prices for each separate sale were not provided.
How did this transaction affect the insider's holdings?
The reported holding fell by 1,381,762 shares to zero. The sales covered 100.00% of the shares held in that balance before the trades. The available details do not show whether he had other holdings.
What's the total transaction value?
The seven sales had a total value of $53,536,738.01. This amount covers all the reported sales from November 16 through November 17, 2026.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement. Filing footnote text was not provided, so further details about how the sales were arranged remain unknown. The available information also does not explain the reason for the sales.
For research purposes only; not investment advice.